XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Long-Term Investments (Details) - Schedule of Long-Term Investment - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Long-Term Investment [Line Items]    
Non-marketable Cost Method Investments, net $ 798,023 $ 847,252
Equity Method Investments, net 2,377,549 2,527,740
Braingenesis Biotechnology Co., Ltd. [Member]    
Schedule of Long-Term Investment [Line Items]    
Non-marketable Cost Method Investments, net 6,794 7,213
Genepharm Biotech Corporation [Member]    
Schedule of Long-Term Investment [Line Items]    
Non-marketable Cost Method Investments, net 20,742 22,021
BioHopeKing Corporation [Member]    
Schedule of Long-Term Investment [Line Items]    
Non-marketable Cost Method Investments, net 770,487 818,018
ForSeeCon Corporation [Member]    
Schedule of Long-Term Investment [Line Items]    
Non-marketable Cost Method Investments, net
BioFirst Corporation [Member]    
Schedule of Long-Term Investment [Line Items]    
Equity Method Investments, net 1,579,526 1,680,488
Rgene Corporation [Member]    
Schedule of Long-Term Investment [Line Items]    
Equity Method Investments, net